Wyoming Tech Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wyoming Tech Reporter.

Press releases published on June 22, 2026

an hour ago

SEALSQ’s QS7001 Post-Quantum Secure Element Aligned with New ANSSI Post Quantum Mandate

Indeterminate GlobeNewswire

an hour ago

Next-Generation DNA Repair Therapies Open New Frontiers in Oncology

Indeterminate GlobeNewswire

an hour ago

Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis

Indeterminate GlobeNewswire

an hour ago

Entera Bio Receives Positive FDA Feedback on 12-Month Registrational Phase 3 Study for EB613 - the First Oral Anabolic Tablet in Development for Postmenopausal Women with Osteoporosis

Indeterminate GlobeNewswire

an hour ago

NewGen Issues 3,666,667 New Shares in Connection with Strategic K25.ai Acquisition, Reaches Milestone of US$7.6 Million Market Capitalization

Indeterminate GlobeNewswire

an hour ago

Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial

Indeterminate GlobeNewswire

an hour ago

Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts 

Indeterminate GlobeNewswire

an hour ago

Outdoor Holding Company Reports Fourth Quarter and Fiscal Year 2026 Financial Results

Indeterminate GlobeNewswire

2 hours ago

Novel Key Terms For Managing CIDP Published in Neurology® Journal

Indeterminate GlobeNewswire

2 hours ago

Refinity Secures Exclusive License to PNNL Catalyst Technology to Convert Olefins into Circular Hydrocarbon Liquids for SAF Production

Indeterminate GlobeNewswire

2 hours ago

EagleNXT Secures Order of eBee VISION ISR and eBee TAC Systems from Asia Pacific Customer

Indeterminate GlobeNewswire

2 hours ago

Medidata Unveils New Academic Board to Bridge the Gap Between Research and Patient Care

Indeterminate GlobeNewswire

2 hours ago

Azure Maps Gen1 Pricing Customers To Be Migrated To Gen2 Pricing in September 2026, A 9x Cost Increase

Indeterminate GlobeNewswire

2 hours ago

Kyverna Therapeutics Appoints Ritesh Srivastava as Chief Legal and Compliance Officer, Adding Leadership Strength to Support Commercial-Stage Transition

Indeterminate GlobeNewswire

2 hours ago

Hyperion DeFi and Blockdaemon Partner to Expand Institutional Hyperliquid Staking Infrastructure

Indeterminate GlobeNewswire

2 hours ago

Revolution Medicines Announces Planned Leadership Transition for Steve Kelsey, M.D.

Indeterminate GlobeNewswire

2 hours ago

Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum

Indeterminate GlobeNewswire

2 hours ago

Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL Phase 1/2 Trials Evaluating TSHA-102 for Rett Syndrome

Indeterminate GlobeNewswire

2 hours ago

Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of Function Variants

Indeterminate GlobeNewswire

2 hours ago

Atsena Therapeutics Doses First Patient and Reports Rapid Early Enrollment in Pivotal Trial of ATSN-201 for X-Linked Retinoschisis

Indeterminate GlobeNewswire